Cite
Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma
MLA
Yichen Tian, et al. “Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma.” Current Cancer Drug Targets, vol. 22, no. 6, Nov. 2021. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....32a38c3c8e54fd36a684f0274e8df775&authtype=sso&custid=ns315887.
APA
Yichen Tian, Yongrong Lei, Yuna Fu, Heng Sun, Jianhua Wang, & Feng Xia. (2021). Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma. Current Cancer Drug Targets, 22(6).
Chicago
Yichen Tian, Yongrong Lei, Yuna Fu, Heng Sun, Jianhua Wang, and Feng Xia. 2021. “Molecular Mechanisms of Resistance to Tyrosine Kinase Inhibitors Associated with Hepatocellular Carcinoma.” Current Cancer Drug Targets 22 (6). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....32a38c3c8e54fd36a684f0274e8df775&authtype=sso&custid=ns315887.